Baudax Bio Analysis
| BXRXDelisted Stock | USD 0.76 0.06 7.32% |
Baudax Bio is overvalued with Real Value of 0.68 and Hype Value of 0.76. The main objective of Baudax Bio delisted stock analysis is to determine its intrinsic value, which is an estimate of what Baudax Bio is worth, separate from its market price. There are two main types of Baudax Bio's stock analysis: fundamental analysis and technical analysis.
The Baudax Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Baudax Bio is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Baudax Stock trading window is adjusted to America/New York timezone.
Baudax |
Baudax Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Baudax Bio recorded a loss per share of 94.13. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 1st of December 2022. Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 80 people. For more info on Baudax Bio please contact Geraldine Henwood at 484 395 2440 or go to https://www.baudaxbio.com.Baudax Bio Investment Alerts
| Baudax Bio is not yet fully synchronised with the market data | |
| Baudax Bio has some characteristics of a very speculative penny stock | |
| Baudax Bio has a very high chance of going through financial distress in the upcoming years | |
| Baudax Bio currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax Bio has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Baudax Bio's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M). | |
| Baudax Bio currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. |
Baudax Bio Upcoming and Recent Events
Earnings reports are used by Baudax Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 14th of November 2023 Upcoming Quarterly Report | View | |
| 22nd of February 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Baudax Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 950.33 K.Baudax Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Baudax Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Baudax Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Baudax Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lake Ryan David over six months ago Disposition of 15064 shares by Lake Ryan David of Baudax BioInc at 1.14 subject to Rule 16b-3 | ||
Kim Yong Chan over six months ago Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3 | ||
Altomari Alfred over six months ago Insider Trading | ||
Kim Yong Chan over a year ago Baudax BioInc exotic insider transaction detected |
Baudax Bio Outstanding Bonds
Baudax Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Baudax Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Baudax bonds can be classified according to their maturity, which is the date when Baudax Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
About Baudax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Baudax Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Baudax shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Baudax Bio. By using and applying Baudax Stock analysis, traders can create a robust methodology for identifying Baudax entry and exit points for their positions.
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 80 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Baudax Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Baudax Stock
If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |